申请人:Takeda Chemical Industries, Ltd.
公开号:US04035512A1
公开(公告)日:1977-07-12
Novel aminotetralol compounds of the formula ##STR1## wherein R.sup.1 is hydrogen, acyl derived from carboxylic acid, or a hydrocarbon group which may be substituted; --OZ.sup.1 is hydroxyl which may be protected; Y is hydrogen, acyl, hydroxyl which may be protected, amino which may be substituted, nitro, cyano or halogen; and n is zero, 1 or 2 with a proviso that when Y is hydrogen or hydroxyl which may be protected, n is not zero, and their salts, have excellent pharmacological activities such as strong bronchodilating activity. They are useful as medicines, for example, for treatment of asthma.
新型氨基四氢萘化合物的化学式为##STR1##其中R.sup.1是氢、来自羧酸的酰基,或者可以被取代的烃基;--OZ.sup.1是可能被保护的羟基;Y是氢、酰基、可能被保护的羟基、可能被取代的氨基、硝基、氰基或卤素;n为零、1或2,但当Y为氢或可能被保护的羟基时,n不为零。这些化合物及其盐具有出色的药理活性,如强效的支气管扩张活性。它们可用作药物,例如用于治疗哮喘。